Affinity Asset Advisors’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Affinity Asset Advisors’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-72,466	Closed	-$1.04M	–	91
2021 Q2	$1.04M	Hold	72,466	–	–	0.37%	53
2021 Q1	$312K	Hold	72,466	–	–	0.11%	69
2020 Q4	$409K	Buy	+72,466	New	+$292K	0.22%	59

Affinity Asset Advisors's CEREW Position: Q3 2021 in Review

Affinity Asset Advisors sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 72,466 shares — an estimated $1.04M sold.

Affinity Asset Advisors first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $1.04M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Affinity Asset Advisors reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Affinity Asset Advisors sold 72,466 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $1.04M.
Affinity Asset Advisors first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Affinity Asset Advisors's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $1.04M in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Affinity Asset Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.